Tanvex BioPharma (Taiwan) Today
| 6541 Stock | TWD 69.80 1.60 2.35% |
Performance7 of 100
| Odds Of DistressLess than 31
|
Tanvex BioPharma is selling for under 69.80 as of the 22nd of November 2024; that is 2.35 percent increase since the beginning of the trading day. The stock's lowest day price was 67.0. Tanvex BioPharma has about a 31 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Tanvex BioPharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. The company has 352.74 M outstanding shares. More on Tanvex BioPharma
Moving against Tanvex Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Tanvex Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Tanvex BioPharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Tanvex BioPharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Lin Chen |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Tanvex BioPharma (6541) is traded on Taiwan Stock Exchange in Taiwan and employs 23 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tanvex BioPharma's market, we take the total number of its shares issued and multiply it by Tanvex BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tanvex BioPharma operates under Healthcare sector and is part of Biotechnology industry. The entity has 352.74 M outstanding shares.
Tanvex BioPharma has accumulated about 1.65 B in cash with (1.39 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29.
Check Tanvex BioPharma Probability Of Bankruptcy
Ownership AllocationTanvex BioPharma shows a total of 352.74 Million outstanding shares. Tanvex BioPharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Tanvex Ownership Details
Tanvex BioPharma Risk Profiles
Although Tanvex BioPharma's alpha and beta are two of the key measurements used to evaluate Tanvex BioPharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.74 | |||
| Semi Deviation | 1.55 | |||
| Standard Deviation | 2.74 | |||
| Variance | 7.51 |
Tanvex Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Tanvex BioPharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Tanvex BioPharma Corporate Management
Elected by the shareholders, the Tanvex BioPharma's board of directors comprises two types of representatives: Tanvex BioPharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tanvex. The board's role is to monitor Tanvex BioPharma's management team and ensure that shareholders' interests are well served. Tanvex BioPharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tanvex BioPharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Val Chen | Director Officer | Profile | |
| Helena Makagiansar | Deputy General Manager-LJB Production Development | Profile | |
| Yongjian Wu | Deputy General Manager-LJB Research & Development | Profile | |
| LungYeh Cho | Director | Profile | |
| Dilip Joshi | VP US | Profile | |
| LeeChiou Chang | Independent Director | Profile |
Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.